27857693|t|Heavy Resistance Training in Hypoxia Enhances 1RM Squat Performance
27857693|a|Purpose: To determine if heavy resistance training in hypoxia (IHRT) is more effective at improving strength, power, and increasing lean mass than the same training in normoxia. Methods: A pair-matched, placebo-controlled study design included 20 resistance-trained participants assigned to IHRT (FIO2 0.143) or placebo (FIO2 0.20), (n = 10 per group). Participants were matched for strength and training. Both groups performed 20 sessions over 7 weeks either with IHRT or placebo. All participants were tested for 1RM, 20-m sprint, body composition, and countermovement jump pre -, mid -, and post - training and compared via magnitude - based inferences. Presentation of Results: Groups were not clearly different for any test at baseline. Training improved both absolute (IHRT: 13.1 ± 3.9%, effect size (ES) 0.60, placebo 9.8 ± 4.7%, ES 0.31) and relative 1RM (IHRT: 13.4 ± 5.1%, ES 0.76, placebo 9.7 ± 5.3%, ES 0.48) at mid. Similarly, at post both groups increased absolute (IHRT: 20.7 ± 7.6%, ES 0.74, placebo 14.1 ± 6.0%, ES 0.58) and relative 1RM (IHRT: 21.6 ± 8.5%, ES 1.08, placebo 13.2 ± 6.4%, ES 0.78). Importantly, the change in IHRT was greater than placebo at mid for both absolute [4.4% greater change, 90% Confidence Interval (CI) 1.0:8.0%, ES 0.21, and relative strength (5.6% greater change, 90% CI 1.0:9.4%, ES 0.31 (relative)]. There was also a greater change for IHRT at post for both absolute (7.0% greater change, 90% CI 1.3:13%, ES 0.33), and relative 1RM (9.2% greater change, 90% CI 1.6:14.9%, ES 0.49). Only IHRT increased countermovement jump peak power at Post (4.9%, ES 0.35), however the difference between IHRT and placebo was unclear (2.7, 90% CI -2.0:7.6%, ES 0.20) with no clear differences in speed or body composition throughout. Conclusion: Heavy resistance training in hypoxia is more effective than placebo for improving absolute and relative strength.
27857693	0	25	Heavy Resistance Training	T061	C0872279
27857693	29	36	Hypoxia	T046	C0242184
27857693	37	45	Enhances	T052	C2349975
27857693	46	49	1RM	T081	C4054321
27857693	50	55	Squat	T033	C0241236
27857693	56	67	Performance	T055	C0597198
27857693	93	118	heavy resistance training	T061	C0872279
27857693	122	129	hypoxia	T046	C0242184
27857693	131	135	IHRT	T061	C0872279
27857693	145	154	effective	T080	C1704419
27857693	158	167	improving	T080	C1272745
27857693	168	176	strength	T081	C0237897
27857693	178	183	power	T033	C0424581
27857693	189	199	increasing	T169	C0442808
27857693	200	209	lean mass	T201	C0424678
27857693	224	232	training	T080	C2673163
27857693	257	269	pair-matched	T080	C0085145
27857693	271	295	placebo-controlled study	T062,T170	C0599724
27857693	296	302	design	T052	C1707689
27857693	315	333	resistance-trained	T061	C0872279
27857693	334	346	participants	T098	C0679646
27857693	359	363	IHRT	T061	C0872279
27857693	365	369	FIO2	T061	C2370852
27857693	380	387	placebo	T096	C0009932
27857693	389	393	FIO2	T061	C2370852
27857693	413	418	group	UnknownType	C0681860
27857693	421	433	Participants	T098	C0679646
27857693	439	446	matched	T080	C1708943
27857693	451	459	strength	T081	C0237897
27857693	464	472	training	T061	C0872279
27857693	474	478	Both	T080	C1706086
27857693	479	485	groups	UnknownType	C0681860
27857693	486	495	performed	T169	C0884358
27857693	499	507	sessions	T051	C1883016
27857693	515	520	weeks	T079	C0439230
27857693	533	537	IHRT	T061	C0872279
27857693	541	548	placebo	T096	C0009932
27857693	554	566	participants	T098	C0679646
27857693	572	578	tested	T169	C0039593
27857693	583	586	1RM	T081	C4054321
27857693	588	592	20-m	T081	C3842775
27857693	593	599	sprint	T061	C0454374
27857693	601	617	body composition	T032	C0005885
27857693	623	643	countermovement jump	T056	C0221189
27857693	644	647	pre	T079	C0332152
27857693	651	654	mid	T079	C1254367
27857693	662	666	post	T079	C0687676
27857693	669	677	training	T061	C0872279
27857693	682	690	compared	T052	C1707455
27857693	695	704	magnitude	T081	C1704240
27857693	707	712	based	T169	C1527178
27857693	713	723	inferences	T041	C0679201
27857693	750	756	Groups	UnknownType	C0681860
27857693	762	773	not clearly	T033	C3845108
27857693	774	783	different	T080	C1705242
27857693	792	796	test	T169	C0039593
27857693	800	808	baseline	T081	C1442488
27857693	810	818	Training	T061	C0872279
27857693	819	827	improved	T033	C0184511
27857693	828	832	both	T080	C1706086
27857693	833	841	absolute	T080	C0205344
27857693	843	847	IHRT	T061	C0872279
27857693	862	873	effect size	T081	C0814843
27857693	875	877	ES	T081	C0814843
27857693	885	892	placebo	T096	C0009932
27857693	905	907	ES	T081	C0814843
27857693	918	926	relative	T080	C0205345
27857693	927	930	1RM	T081	C4054321
27857693	932	936	IHRT	T061	C0872279
27857693	951	953	ES	T081	C0814843
27857693	960	967	placebo	T096	C0009932
27857693	980	982	ES	T081	C0814843
27857693	1011	1015	post	T079	C0687676
27857693	1016	1020	both	T080	C1706086
27857693	1021	1027	groups	UnknownType	C0681860
27857693	1028	1037	increased	T081	C0205217
27857693	1038	1046	absolute	T080	C0205344
27857693	1048	1052	IHRT	T061	C0872279
27857693	1067	1069	ES	T081	C0814843
27857693	1076	1083	placebo	T096	C0009932
27857693	1097	1099	ES	T081	C0814843
27857693	1110	1118	relative	T080	C0205345
27857693	1119	1122	1RM	T081	C4054321
27857693	1124	1128	IHRT	T061	C0872279
27857693	1143	1145	ES	T081	C0814843
27857693	1152	1159	placebo	T096	C0009932
27857693	1173	1175	ES	T081	C0814843
27857693	1200	1206	change	T169	C0392747
27857693	1210	1214	IHRT	T061	C0872279
27857693	1219	1226	greater	T081	C1704243
27857693	1232	1239	placebo	T096	C0009932
27857693	1251	1255	both	T080	C1706086
27857693	1256	1264	absolute	T080	C0205344
27857693	1271	1278	greater	T081	C1704243
27857693	1279	1285	change	T169	C0392747
27857693	1291	1310	Confidence Interval	T081	C0009667
27857693	1312	1314	CI	T081	C0009667
27857693	1326	1328	ES	T081	C0814843
27857693	1339	1347	relative	T080	C0205345
27857693	1348	1356	strength	T081	C0237897
27857693	1363	1370	greater	T081	C1704243
27857693	1371	1377	change	T169	C0392747
27857693	1383	1385	CI	T081	C0009667
27857693	1396	1398	ES	T081	C0814843
27857693	1405	1413	relative	T080	C0205345
27857693	1434	1441	greater	T081	C1704243
27857693	1442	1448	change	T169	C0392747
27857693	1453	1457	IHRT	T061	C0872279
27857693	1470	1474	both	T080	C1706086
27857693	1475	1483	absolute	T080	C0205344
27857693	1490	1497	greater	T081	C1704243
27857693	1498	1504	change	T169	C0392747
27857693	1510	1512	CI	T081	C0009667
27857693	1522	1524	ES	T081	C0814843
27857693	1536	1544	relative	T080	C0205345
27857693	1545	1548	1RM	T081	C4054321
27857693	1555	1562	greater	T081	C1704243
27857693	1563	1569	change	T169	C0392747
27857693	1575	1577	CI	T081	C0009667
27857693	1589	1591	ES	T081	C0814843
27857693	1604	1608	IHRT	T061	C0872279
27857693	1609	1618	increased	T081	C0205217
27857693	1619	1639	countermovement jump	T056	C0221189
27857693	1640	1644	peak	T080	C0444505
27857693	1645	1650	power	T033	C0424581
27857693	1654	1658	Post	T079	C0687676
27857693	1666	1668	ES	T081	C0814843
27857693	1688	1698	difference	T080	C1705242
27857693	1707	1711	IHRT	T061	C0872279
27857693	1716	1723	placebo	T096	C0009932
27857693	1728	1735	unclear	T033	C3845108
27857693	1746	1748	CI	T081	C0009667
27857693	1760	1762	ES	T081	C0814843
27857693	1774	1782	no clear	T033	C3845108
27857693	1783	1794	differences	T080	C1705242
27857693	1798	1803	speed	T081	C0678536
27857693	1807	1823	body composition	T032	C0005885
27857693	1848	1873	Heavy resistance training	T061	C0872279
27857693	1877	1884	hypoxia	T046	C0242184
27857693	1893	1902	effective	T080	C1704419
27857693	1908	1915	placebo	T096	C0009932
27857693	1920	1929	improving	T080	C1272745
27857693	1930	1938	absolute	T080	C0205344
27857693	1943	1951	relative	T080	C0205345
27857693	1952	1960	strength	T081	C0237897